Clinicians’ lack of obesity management knowledge may foil optimal treatment. This activity incorporates a “Man-on-the-Street” video to increase clinician awareness of patient perspectives on obesity management. Evidence-based and expert recommendations on talking with patients about obesity and means to address obstacles in long-term management, will be presented.
Obesity has reached epidemic levels in the U.S., and it is a contributor to the development of diabetes, cardiovascular disease, obstructive sleep apnea, some forms of cancer, and many other diseases. It is imperative that primary care clinicians incorporate obesity care into their medical practice. This presentation will address a practical and time efficient approach for the assessment of patients with obesity and help to formulate a treatment plan. The medical paradigm of lifestyle management, pharmacotherapy, and bariatric surgery will be reviewed along with guidance on how to intensify therapy when indicated.
Clinicians’ lack of obesity management knowledge may foil optimal treatment. This activity incorporates a “Man-on-the-Street” video to increase clinician awareness of patient perspectives on obesity. Evidence-based and expert recommendations on talking with patients about obesity, therapeutic options—including pharmacotherapy—and means to address obstacles in long-term management will be presented.
Obesity is now recognized as a chronic illness that requires ongoing treatment, much like diabetes, hypertension, and hyperlipidemia. This is now encompassed by Obesity Medicine, the fastest-growing new specialty. In this keynote talk, Dr. Louis Aronne discusses multidisciplinary approaches to combating obesity, including prescription of diet, exercise, and behavioral modification. He will further review pharmacologic therapies, devices, and surgeries that can be considered as adjuncts to lifestyle interventions in appropriate patients.
There are emerging epidemics of obesity, metabolic syndrome, and type 2 diabetes mellitus in the U.S. and around the world. In this session, you will receive valuable pharmacological and non-pharmacological tools to combat these conditions in the primary care setting. The faculty will share their experience in providing care with a multidisciplinary team, use of meal replacements, and personalized weight loss plans based on body composition and lifestyle.
Many physicians consciously (or unconsciously) avoid talking to patients about weight loss, although 70% of American adults are overweight or obese. Meanwhile, the public is constantly bombarded with “solutions” that don’t work from friends, social media, and beyond. How can we compete with that volume of misinformation in a fifteen-minute office visit? There are two tools that can empower providers to address obesity in an effective and efficient manner: motivational interviewing and dietary recalls. This talk will teach the basic introductory skills needed to immediately incorporate these interventions into your practice. Additionally, this talk will address the popular gluten-free diet, and how it may or may not help patients beyond those diagnosed with celiac disease. The more physicians prioritize dietary interventions, the more our patients will, too.
Lifestyle intervention is the primary step of obesity management. Multidisciplinary approach was shown to be effective on short and long-term. Several obesity medications are available and are effective for weight management with reasonable risk. Combining medications with lifestyle is more effective then either alone. Bariatric surgery is valuable for patients with severe obesity, but long-term consequences should be carefully evaluated against their benefit.
Primary care health providers play an important role in getting patients to adopt healthy behaviors and make positive lifestyle changes. Learn to apply patient-centric communication strategies such as open-ended questioning, affirmations and reflective listening to get patients to initiate changes.
In this case presentation, Dr. Lee shares strategies for designing basal insulin regimens considering patient comorbidities and socioeconomic factors, highlights the differences between conventional and newer basal insulins, and describes how to appropriately initiate and dose newer basal insulin products in patients with type 2 diabetes.
Get your questions answered by expert faculty in Endocrinology. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice.
This talk will be aimed for primary care physicians with a goal of understanding and defining CKD as its prevalence continues to rise in the era of hypertension, diabetes and obesity epidemics. The attendant will understand and identify patients at risk and with CKD and the natural course of the disease. They will be supplied with tools clinically proven to slow down progression of the disease and understand the denouement of CKD.
Join this lecture for an overview of the pathophysiology, evaluation, and management of patients with nonalcoholic fatty liver disease. The faculty will review current concepts, disease progression, and therapeutics. You will learn about surgical treatments and their impact in patients with nonalcoholic steatohepatitis and obesity as well as the risk for hepatocellular carcinoma.